Luke Nathaniel Walker - 26 Nov 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Frank J. Lanza, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 Nov 2023
Net transactions value
$0
Form type
4
Filing time
28 Nov 2023, 16:32:38 UTC
Previous filing
26 Jan 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HARP Common Stock Award $0 +20,000 $0.000000 20,000 26 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, issuable upon the vesting and settlement of RSUs.
F2 25% of the RSUs will vest on each May 26th and November 26th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.